Details for Patent: 7,125,875
✉ Email this page to a colleague
Summary for Patent: 7,125,875
Title: | Cyclic protein tyrosine kinase inhibitors |
Abstract: | Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders. |
Inventor(s): | Das; Jagabandhu (Mercerville, NJ), Padmanabha; Ramesh (Hamden, CT), Chen; Ping (Belle Mead, NJ), Norris; Derek J. (Trenton, NJ), Doweyko; Arthur M. P. (Long Valley, NJ), Barrish; Joel C. (Richboro, PA), Wityak; John (Robbinsville, NJ), Lombardo; Louis J. (Belle Mead, NJ), Lee; Francis Y. F. (Yardley, PA) |
Assignee: | Bristol-Myers Squibb Company (Princeton, NJ) |
Application Number: | 10/395,503 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,125,875 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 7,125,875
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,125,875
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 044506 | ⤷ Try a Trial | |||
Austria | 464898 | ⤷ Try a Trial | |||
Australia | 2004223828 | ⤷ Try a Trial | |||
Australia | 4233800 | ⤷ Try a Trial | |||
Australia | 779089 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |